Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · Real-Time Price · USD
1.710
-0.020 (-1.16%)
Nov 22, 2024, 4:00 PM EST - Market closed
Ikena Oncology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 83 | 95 | 96 | 450 | - | - | |
| Market Cap Growth | -56.01% | -1.43% | -78.58% | - | - | - | |
| Enterprise Value | -47 | -59 | -72 | 212 | - | - | |
| Last Close Price | 1.71 | 1.97 | 2.66 | 12.54 | - | - | |
| PS Ratio | 124.97 | 10.38 | 6.18 | 14.53 | - | - | |
| PB Ratio | 0.61 | 0.56 | 0.66 | 2.17 | - | - | |
| P/TBV Ratio | 0.62 | 0.56 | 0.66 | 2.17 | - | - | |
| EV/Sales Ratio | - | - | - | 6.83 | - | - | |
| Debt / Equity Ratio | 0.06 | 0.06 | 0.04 | 0.03 | 0.00 | - | |
| Asset Turnover | 0.00 | 0.05 | 0.07 | 0.15 | 0.07 | 0.26 | |
| Quick Ratio | 14.94 | 12.35 | 7.30 | 8.54 | 5.74 | 3.38 | |
| Current Ratio | 15.32 | 12.58 | 7.44 | 8.70 | 5.86 | 3.51 | |
| Return on Equity (ROE) | -37.08% | -43.04% | -38.76% | -21.81% | -72.35% | -98.52% | |
| Return on Assets (ROA) | -22.06% | -25.87% | -21.10% | -10.25% | -21.88% | -21.67% | |
| Return on Capital (ROIC) | -23.54% | -28.30% | -24.12% | -13.34% | -45.42% | -67.71% | |
| Earnings Yield | -72.22% | -71.70% | -71.30% | -7.58% | - | - | |
| FCF Yield | -74.92% | -84.32% | -78.32% | -13.77% | - | - | |
| Buyback Yield / Dilution | -24.03% | -15.33% | -29.32% | -911.88% | -4.43% | -55.37% | |
| Total Shareholder Return | -24.03% | -15.33% | -29.32% | -911.88% | -4.43% | -55.37% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.